US · USD
RVMD
Revolution Medicines Inc
- Day's range
- US$204.07 – US$208.82
- Day's volume
- US$324.3m
- 52-week range
- US$46.57 – US$221.15
Follow RVMD on Fuolio
See how RVMD weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountRVMD in numbers
- Market cap
- US$44.3bn
- P/E
- -25.05
- P/B
- 16.99
- Dividend yield (12m)
- 0.00%
RVMD price history
RVMD risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +165.74% | +785.73% | +647.07% |
| Volatility (annualised) | 50.66% | 47.49% | 52.17% |
| Largest drawdown | -4.68% | -38.88% | -41.71% |
| Positive months | 10/12 | 26/36 | 39/60 |
How much did investing in RVMD return?
US$1,000.00 invested on 01/11/2021 would be worth US$7,470.72 today.
- Value today in RVMD
- US$7,470.72
- Return over the period
- +647.07%
- Return per year
- +50.53%
- In the S&P 500
- US$1,690.98
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
RVMD fundamentals
Valuation
- P/E-25.05
- P/B16.99
- EV/EBITDA-27.36
- EV/EBIT-27.22
- EV/Revenue—
- P/EBIT-27.22
- P/S—
- P/OCF-36.21
- P/FCF-35.95
- Earnings yield-3.67%
- PEG ratio—
- Earnings per share-US$8.25
- Book value per shareUS$12.16
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio11.38
- Quick ratio—
- Cash ratio11.12
Profitability
- ROE-67.84%
- ROA-40.89%
- ROIC-62.44%
- Payout—
RVMD indicators by year
Multiples at each year's closing price; margins and returns from that year's accounts.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | -13.96 | -13.55 | -10.83 | -8.66 | -9.99 | -26.86 | — | — |
| P/B | 9.68 | 3.59 | 2.59 | 3.15 | 3.10 | 6.12 | — | — |
| Earnings per share | -US$5.71 | -US$3.23 | -US$2.65 | -US$2.75 | -US$2.52 | -US$1.47 | — | — |
| Book value per share | US$8.23 | US$12.18 | US$11.09 | US$7.57 | US$8.12 | US$6.47 | — | — |
| ROE | -69.33% | -26.49% | -23.87% | -36.34% | -31.03% | -22.79% | 31.24% | 38.54% |
| ROIC | -72.48% | -30.40% | -26.46% | -37.63% | -31.20% | -23.24% | — | — |
| EBITDA margin | — | — | -4,163.95% | -718.79% | -629.21% | -251.46% | -103.61% | -192.23% |
| Net margin | — | — | -3,765.11% | -703.79% | -636.27% | -251.63% | -95.25% | -207.24% |
RVMD financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | US$0 | US$0 | US$11.6m | US$35.4m | US$29.4m | US$43m |
| Cost of sales | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| EBITDA | -US$1.2bn | -US$683m | -US$482.2m | -US$254.3m | -US$184.9m | -US$108.1m |
| EBIT | -US$1.2bn | -US$689.5m | -US$487.2m | -US$258.3m | -US$188m | -US$110.7m |
| Net finance result | US$51.1m | US$88.7m | US$47.3m | US$9.2m | US$917k | US$2.2m |
| Profit before tax | -US$1.1bn | -US$600.8m | -US$439.9m | -US$249.1m | -US$187.1m | -US$108.5m |
| Income tax | -US$0 | US$753k | US$3.5m | US$420k | -US$0 | US$371k |
| Net income | -US$1.1bn | -US$600m | -US$436m | -US$249m | -US$187m | -US$108.2m |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does RVMD pay dividends?
RVMD has no distributions on record.
About Revolution Medicines
- Sector
- Manufacturing
Questions about RVMD
How much is RVMD today?
RVMD is at US$206.64 (0.36% on the day), last traded on 02/10/2026.
What are the P/E and P/B of RVMD?
RVMD trades at a P/E of -25.05 and a P/B of 16.99.
How much did RVMD return in 12 months?
RVMD returned 165.74% in 12 months, with annualised volatility of 50.66% and a largest drawdown of -4.68%.